Company
Nautilus Biotechnology, Inc. (NAUT)
Standardized SEC financial data for Nautilus Biotechnology, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001808805 · NASDAQ · Laboratory Analytical Instruments.
Return on equity
-37.6%
Free cash flow
-$52.0M
Current ratio
13.32×
EPS (diluted)
$-0.47
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $12.4M | $29.4M | $37.7M | $47.3M | $50.5M | $41.1M |
| SG&A expense |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $345.7M | $184.5M | $173.4M | $129.9M | $103.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.0M | -$39.2M | -$45.8M | -$51.7M | -$59.1M | -$50.7M |
| Capital expenditures |
Get NAUT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NAUT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NAUT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"